1. Market Research
Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

  • All
    • Global Markets Direct
11 reports for Cigar (page 1)

Purchase Reports From Reputable Market Research Publishers

Neuronal Acetylcholine Receptor Subunit Beta 2 - Pipeline Review, H1 2020

  • $ 3500
  • March 2020
  • 55 pages

cigars or smokeless tobacco, and how we can support the development of such therapies. "

  • Cigar
  • Pharmaceutical
  • Smoking Cessation
  • Therapy
  • United States

Neuronal Acetylcholine Receptor Subunit Alpha 4 - Pipeline Review, H1 2020

  • $ 3500
  • March 2020
  • 59 pages

cigars or smokeless tobacco, and how we can support the development of such therapies. "

  • Cigar
  • Pharmaceutical
  • Smoking Cessation
  • United States
  • Product Initiative

Neuronal Acetylcholine Receptor Subunit Alpha 4 - Pipeline Review, H2 2019

  • $ 3500
  • December 2019
  • 59 pages

cigars or smokeless tobacco, and how we can support the development of such therapies. "

  • Cigar
  • OTC
  • Smoking Cessation
  • United States
  • Product Initiative

Neuronal Acetylcholine Receptor Subunit Beta 2 - Pipeline Review, H2 2019

  • $ 3500
  • December 2019
  • 59 pages

cigars or smokeless tobacco, and how we can support the development of such therapies. "

  • Cigar
  • OTC
  • Smoking Cessation
  • United States
  • Product Initiative

Receptor Tyrosine Protein Kinase ERBB 4 - Pipeline Review, H2 2019

  • $ 3500
  • December 2019
  • 151 pages

This study will explore the safety and efficacy of the oral PanHER inhibitor PF-## in patients with adenocarcinoma of the lung who are either non-smokers (## cigarette, cigar or pipe lifetime) or former light smokers ( less than ## pack-years and stopped at least ## years) or have kn

  • Breast Cancer
  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • Therapy

Receptor Tyrosine Protein Kinase ERBB 4 (Tyrosine Kinase Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1) - Pipeline Review, H2 2018

  • $ 3500
  • August 2018
  • 127 pages

THIS STUDY WILL EXPLORE THE SAFETY AND EFFICACY OF THE ORAL PANHER INHIBITOR PF-## IN PATIENTS WITH ADENOCARCINOMA OF THE LUNG WHO ARE EITHER NON-SMOKERS (## CIGARETTE, CIGAR OR PIPE LIFETIME) OR FORMER LIGHT SMOKERS ( LESS THAN ## PACK-YEARS AND STOPPED AT LEAST ## YEARS) OR HAVE KN

  • Breast Cancer
  • Gastrointestinal Drug
  • Hospital
  • Pharmaceutical
  • Therapy

Receptor Tyrosine Protein Kinase ERBB 4 (Tyrosine Kinase Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1) - Pipeline Review, H1 2018

  • $ 3500
  • February 2018
  • 120 pages

This study will explore the safety and efficacy of the oral PanHER inhibitor PF-## in patients with adenocarcinoma of the lung who are either non-smokers (## cigarette, cigar or pipe lifetime) or former light smokers ( less than ## pack-years and stopped at least ## years) or have kn

  • Gastrointestinal Drug
  • Hospital
  • Lung Cancer
  • Pharmaceutical
  • Therapy

Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016

  • $ 2000
  • April 2016
  • 434 pages

This study will explore the safety and efficacy of the oral PanHER inhibitor PF-## in patients with adenocarcinoma of the lung who are either non-smokers (## cigarette, cigar or pipe lifetime) or former light smokers ( less than ## pack-years and stopped at least ## years) or have kn

  • Brain Cancer
  • Hospital
  • Targeted Therapy
  • Therapy
  • Merck & Co., Inc.

Metastatic Pancreatic Cancer - Pipeline Review, H1 2016

  • $ 2000
  • March 2016
  • 456 pages

This study will explore the safety and efficacy of the oral PanHER inhibitor PF-## in patients with adenocarcinoma of the lung who are either non-smokers (## cigarette, cigar or pipe lifetime) or former light smokers ( less than ## pack-years and stopped at least ## years) or have kn

  • Chemotherapy
  • Pancreatic Cancer
  • Pharmaceutical
  • Targeted Therapy
  • Therapy

Metastatic Colorectal Cancer - Pipeline Review, H1 2016

  • $ 2000
  • May 2016
  • 718 pages

This study will explore the safety and efficacy of the oral PanHER inhibitor PF-## in patients with adenocarcinoma of the lung who are either non-smokers (## cigarette, cigar or pipe lifetime) or former light smokers ( less than ## pack-years and stopped at least ## years) or have kn

  • Colorectal Cancer
  • Hospital
  • Monoclonal Antibody
  • Targeted Therapy
  • Therapy

Pfizer Inc. - Product Pipeline Review - 2016

  • $ 1500
  • March 2016
  • 419 pages

This study will explore the safety and efficacy of the oral PanHER inhibitor PF-## in patients with adenocarcinoma of the lung who are either non-smokers (## cigarette, cigar or pipe lifetime) or former light smokers ( less than ## pack-years and stopped at least ## years) or have kn

  • Monoclonal Antibody
  • Pathology
  • Targeted Therapy
  • Therapy
  • Pfizer Inc.


View report >

Cigar and Tobacco Exports in Dominican Republic

  • October 2019
  • 4 pages

Today' s launch of the cigar festival represents a timely intervention for cigar manufacturers in the dominican republic to expand their sales of cigars in trinidad and tobago.

  • Cigar
  • Tobacco
  • Dominican Republic
  • Trade

Cigarette Price October 2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on